Benign Prostatic Hyperplasia (NICE TA273 - terminated appraisal)
NICE TA273 - Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)
This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria